Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Aligos Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-10-20
Purchase
2020-10-22
4:31 pm
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
200,000 $15 $3,000,000 2,614,563
(Direct)
View
2020-10-20
Purchase
2020-10-20
5:00 pm
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
200,000 $15 $3,000,000 862,444
(Indirect)
View
2020-10-20
Purchase
2020-10-20
4:59 pm
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
550,000 $15 $8,250,000 430,372
(Indirect)
View
2020-10-20
Purchase
2020-10-20
4:58 pm
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
200,000 $15 $3,000,000 3,292,339
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-23
Option Award
2022-06-27
4:14 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
15,000 $0 15,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:14 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Hirth Peter
Director
15,000 $0 15,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:13 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Scopa James Paul
Director
15,000 $0 15,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:13 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Nielsen Jack
Director
15,000 $0 15,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:12 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
15,000 $0 15,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:11 pm
N/A
2032-06-23
Aligos Therapeutics Inc. ALGS Martell Bridget A
Director
15,000 $0 15,000
(Direct)
View
2022-04-27
Ownership
2022-05-06
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS McClure Matthew W.
Chief Medical Officer
0 $0 515,478
(Indirect)
View
2022-02-08
Option Award
2022-02-08
4:09 pm
N/A
2032-02-04
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
131,250 $0 131,250
(Direct)
View
2022-02-04
Option Award
2022-02-08
4:09 pm
N/A
2032-02-04
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
404,250 $0 404,250
(Direct)
View
2022-02-04
Option Award
2022-02-08
4:08 pm
N/A
2032-02-04
Aligos Therapeutics Inc. ALGS Calhoun Lesley Ann
See Remarks
131,250 $0 131,250
(Direct)
View
2022-02-04
Option Award
2022-02-08
4:07 pm
N/A
2032-02-04
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
131,250 $0 131,250
(Direct)
View
2022-02-04
Option Award
2022-02-08
4:07 pm
N/A
2032-02-04
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
283,500 $0 283,500
(Direct)
View
2021-11-16
Option Award
2021-11-18
4:38 pm
N/A
2031-11-16
Aligos Therapeutics Inc. ALGS Martell Bridget A
Director
30,000 $0 30,000
(Direct)
View
2021-06-17
Option Award
2021-06-17
6:46 pm
N/A
2031-06-17
Aligos Therapeutics Inc. ALGS Nielsen Jack
Director
15,000 $0 15,000
(Direct)
View
2021-06-17
Option Award
2021-06-17
5:14 pm
N/A
2031-06-17
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
15,000 $0 15,000
(Direct)
View
2021-06-17
Option Award
2021-06-17
5:13 pm
N/A
2031-06-17
Aligos Therapeutics Inc. ALGS Hirth Peter
Director
15,000 $0 15,000
(Direct)
View
2021-06-17
Option Award
2021-06-17
5:09 pm
N/A
2031-06-17
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
15,000 $0 15,000
(Direct)
View
2021-06-11
Other
2021-06-15
4:43 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
506,307 $0 1,391,305
(Indirect)
View
2021-04-26
Other
2021-04-28
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
506,310 $0 1,389,085
(Indirect)
View
2021-04-26
Option Award
2021-04-27
4:42 pm
N/A
2031-04-26
Aligos Therapeutics Inc. ALGS Scopa James Paul
Director
30,000 $0 30,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:05 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
200,000 $0 200,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:04 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Calhoun Lesley Ann
See Remarks
176,237 $0 176,237
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:04 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
200,000 $0 200,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:03 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
300,000 $0 300,000
(Direct)
View
2020-12-01
Option Award
2020-12-03
8:03 pm
N/A
2030-12-01
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
450,000 $0 450,000
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:31 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
4,829,126 $0 2,614,563
(Direct)
View
2020-10-20
Conversion
2020-10-22
4:12 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
1,906,191 $0 1,906,191
(Direct)
View
2020-10-20
Conversion
2020-10-20
5:00 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
3,092,339 $0 862,444
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:59 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
2,997,030 $0 430,372
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:58 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Versant Venture Capital VI L.P.
Versant Vantage I L.P.
10% Owner
3,092,339 $0 3,292,339
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:57 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Symons Julian A.
See Remarks
18,517 $0 394,064
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:56 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Quan Lucinda Y.
See Remarks
9,258 $0 384,805
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Nuechterlein Carole
Director
3,092,340 $0 3,092,340
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS BLATT LAWRENCE
CEO
273,058 $0 1,255,815
(Indirect)
View
2020-10-20
Conversion
2020-10-20
4:53 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Beigelman Leonid
President
273,057 $0 1,255,650
(Indirect)
View
2020-10-15
Ownership
2020-10-15
7:50 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner
0 $0 1,906,191
(Direct)
View
2020-10-15
Ownership
2020-10-15
7:16 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Novo Holdings A/S
10% Owner
0 $0 2,414,563
(Direct)
View
2020-10-15
Ownership
2020-10-15
5:17 pm
N/A
N/A
Aligos Therapeutics Inc. ALGS Woiwode Thomas
Director
0 $0 3,092,339
(Indirect)
View
Goto 0, 1, Next